MX2011012614A - Compuestos de quetolida que tienen actividad antimicrobiana. - Google Patents

Compuestos de quetolida que tienen actividad antimicrobiana.

Info

Publication number
MX2011012614A
MX2011012614A MX2011012614A MX2011012614A MX2011012614A MX 2011012614 A MX2011012614 A MX 2011012614A MX 2011012614 A MX2011012614 A MX 2011012614A MX 2011012614 A MX2011012614 A MX 2011012614A MX 2011012614 A MX2011012614 A MX 2011012614A
Authority
MX
Mexico
Prior art keywords
antimicrobial activity
ketolide compounds
compounds
ketolide
compound
Prior art date
Application number
MX2011012614A
Other languages
English (en)
Inventor
Bharat Kalidas Trivedi
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2011012614A publication Critical patent/MX2011012614A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a compuestos de quetolida de la fórmula I y a sus sales aceptables para uso farmacéutico, que tienen actividad antimicrobiana. La invención provee también composiciones farmacéuticas que contienen los compuestos de la invención, y métodos para tratar o prevenir infecciones microbianas con el compuesto de la invención.
MX2011012614A 2009-05-27 2010-05-26 Compuestos de quetolida que tienen actividad antimicrobiana. MX2011012614A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1307MU2009 2009-05-27
PCT/IB2010/052325 WO2010136971A1 (en) 2009-05-27 2010-05-26 Ketolide compounds having antimicrobial activity

Publications (1)

Publication Number Publication Date
MX2011012614A true MX2011012614A (es) 2012-02-22

Family

ID=42731985

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011012614A MX2011012614A (es) 2009-05-27 2010-05-26 Compuestos de quetolida que tienen actividad antimicrobiana.

Country Status (14)

Country Link
US (1) US8541420B2 (es)
EP (1) EP2435460B1 (es)
JP (1) JP5607149B2 (es)
KR (1) KR101566053B1 (es)
CN (1) CN102459296B (es)
AU (1) AU2010252641B2 (es)
BR (1) BRPI1011959A2 (es)
CA (1) CA2763246C (es)
ES (1) ES2561332T3 (es)
MX (1) MX2011012614A (es)
NZ (1) NZ596628A (es)
RU (1) RU2011153353A (es)
WO (1) WO2010136971A1 (es)
ZA (1) ZA201108844B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011340204B2 (en) * 2010-12-09 2016-04-14 Wockhardt Limited Ketolide compounds
ES2603227T3 (es) 2011-03-22 2017-02-24 Wockhardt Limited Proceso para la preparación de compuestos cetólidos
ITMI20130444A1 (it) * 2013-03-22 2014-09-23 S B M Science Of Biology In Medici Ne Srl Composto di inclusione comprendente adjudin [1-(2,4-diclorobenzil) - 1h-indazolo-3-carboidrazide] e ciclodestrina, sua preparazione e utilizzo.
CN105339368B (zh) 2013-06-04 2017-08-15 拜耳制药股份公司 3‑芳基‑取代的咪唑并[1,2‑a]吡啶及其用途
CN106459090A (zh) 2014-02-19 2017-02-22 拜耳制药股份公司 3‑(嘧啶‑2‑基)咪唑并[1,2‑a]吡啶
EP3131555A1 (en) * 2014-04-18 2017-02-22 Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
WO2016087343A1 (de) 2014-12-02 2016-06-09 Bayer Pharma Aktiengesellschaft Heteroaryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
EP3402487A1 (en) * 2016-01-12 2018-11-21 Wockhardt Limited Pharmaceutical compositions for the treatment of bacterial infections
KR20180101509A (ko) * 2016-01-12 2018-09-12 욱크하르트 리미티드 약학 조성물
CN108778254B (zh) * 2016-01-12 2020-09-04 沃克哈特有限公司 药物组合物
KR20190129863A (ko) * 2017-03-16 2019-11-20 욱크하르트 리미티드 케톨라이드 화합물의 제조 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DE69733369T2 (de) 1996-09-04 2006-01-26 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirking
CO4990960A1 (es) * 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
EP0952157B1 (en) * 1998-04-24 2003-06-18 Pfizer Products Inc. 9A, 11B-Dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin
BR0113472A (pt) * 2000-08-22 2003-07-01 Basilea Pharmaceutica Ag Macrolìdeos com atividade antibacteriana
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
PL365012A1 (en) 2000-12-21 2004-12-27 Glaxo Group Limited Macrolide antibiotics
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US7163924B2 (en) 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
ES2322775T3 (es) * 2005-02-09 2009-06-26 Basilea Pharmaceutica Ag Nuevos macrolidos.
KR20090042971A (ko) * 2006-08-24 2009-05-04 욱크하르트 리서치 센터 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드

Also Published As

Publication number Publication date
RU2011153353A (ru) 2013-07-10
KR20120037916A (ko) 2012-04-20
WO2010136971A1 (en) 2010-12-02
US8541420B2 (en) 2013-09-24
US20120142710A1 (en) 2012-06-07
ES2561332T3 (es) 2016-02-25
AU2010252641B2 (en) 2015-09-17
CN102459296B (zh) 2014-10-29
CA2763246C (en) 2013-10-29
JP2012528142A (ja) 2012-11-12
EP2435460A1 (en) 2012-04-04
CA2763246A1 (en) 2010-12-02
BRPI1011959A2 (pt) 2016-04-26
EP2435460B1 (en) 2015-01-07
AU2010252641A1 (en) 2011-12-15
NZ596628A (en) 2013-03-28
CN102459296A (zh) 2012-05-16
JP5607149B2 (ja) 2014-10-15
KR101566053B1 (ko) 2015-11-04
ZA201108844B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
NZ596628A (en) Ketolide compounds having antimicrobial activity
EP3216798A3 (en) Ketolide compounds
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
SG178952A1 (en) Chemical compounds
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
IN2012DN01233A (es)
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
MD4556C1 (ro) Compuşi inhibitori ai activităţii catehol O-metiltransferazei
WO2013106761A3 (en) Antimicrobial agents
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
UA102709C2 (uk) Протимікробна композиція
MX2011008043A (es) Derivados de actagardina.
MX2013004162A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1.
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
MX351555B (es) Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea.
NZ592392A (en) PHENANTHROINDOLIZIDINE COMPOUND AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TN2012000105A1 (en) Spirolactam derivatives and uses of same
HK1137947A1 (en) Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
WO2012073214A3 (en) Heptose derivatives for use in the treatment of bacterial infections
MX2009009074A (es) Macrolidos basados en eritromicina.
JO2820B1 (en) Combination of refined thiazolium salt or a primary compound and artemisinin or a derivative thereof to treat serious malaria cases
MX2012004282A (es) Composiciones farmaceuticas.
MX2010014248A (es) Nuevos antibioticos de trinem e inhibidores de beta-lactamasas.

Legal Events

Date Code Title Description
FG Grant or registration